For decades, treating brain cancer and central nervous system (CNS) disorders has been one of medicine’s toughest battles, largely because of the blood-brain barrier (BBB)—a natural defense that blocks most therapies from reaching the brain. While this barrier protects the brain, it also limits treatment options, leaving patients with few solutions and diminished hope. Today, advancem... https://thelifesciencesmagazine.com/neonc-technologies-holdings-inc/